D. K. Ganguly
D. K. Ganguly | |
---|---|
Born |
Kolkata, West Bengal, India | January 4, 1940
Nationality | Indian |
Fields | |
Institutions | |
Known for | Studies on Parkinsonism |
Notable awards |
Dilip Kumar Ganguly (born 1940) is an Indian neurophysiologist, neuropharmacologist,[1] and a former head of the Department of Pharmacology and Experimental Therapeutics and director of the Indian Institute of Chemical Biology.[2][3] Born on 4 January 1940 in Kolkata, in the Indian state of West Bengal, he is known for his researches on Parkinsonism[4] as well as for his efforts in promoting neuropharmacological studies in India,[5] and his researches have been documented by way of several articles in per-reviewed journals.[6][note 1] Besides, he has contributed chapters to books published by others[3] and his work has been cited by any researchers.[7][8][9] He is a founder fellow of the Indian Academy of Neurosciences and has served as its vice president.[10] The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 1985.[11]
Selected bibliography
- D. K. Ganguly (1976). "Antioxotremorine action of propranolol". British Journal of Pharmacology. 56 (1). doi:10.1111/j.1476-5381.1976.tb06953.x.
- Seth P, Gajendiran M, Maitra KK, Ross HG, Ganguly DK. (1993). "Evidence for D1 dopamine receptor-mediated modulation of the synaptic transmission from motor axon collaterals to Renshaw cells in the rat spinal cord". Neurosci Lett. 158 (2): 217–20. PMID 8233099. doi:10.1016/0304-3940(93)90268-p.
- Gajendiran M, Seth P, Ganguly DK (1996). "Involvement of the presynaptic dopamine D2 receptor in the depression of spinal reflex by apomorphine". Neuroreport. 7 (2): 513–6. PMID 8730818. doi:10.1097/00001756-199601310-00033.
- Gupta S1, Chaudhuri T, Ganguly DK, Giri AK (2001). "Anticlastogenic effects of black tea (World blend) and its two active polyphenols theaflavins and thearubigins in vivo in Swiss albino mice". Life Sci. 69 (23): 2735–44. doi:10.1002/ptr.1038.
- Das M, Sur P, Gomes A, Vedasiromoni JR, Ganguly DK (2002). "Inhibition of tumour growth and inflammation by consumption of tea". Phytother Res. 16 (Supp. 1): 40–4. PMID 11933138.
Notes
- ↑ Please see Selected bibliography section
References
- ↑ Shrikant Mishra, Bhavesh Trikamji, Sandeep Singh, Parampreet Singh, Rajasekharan Nair (2013). "Historical perspective of Indian neurology". Ann Indian Acad Neurol. 16 (4): 467–477. doi:10.4103/0972-2327.120422.
- ↑ "Dogs freed fro lab". The Telegraph. 2017.
- 1 2 Alexander Storch; Michael A. Collins (6 December 2012). Neurotoxic Factors in Parkinson’s Disease and Related Disorders. Springer Science & Business Media. pp. 322–. ISBN 978-1-4615-1269-1.
- ↑ "Brief Profile of the Awardee". Shanti Swarup Bhatnagar Prize. 2017.
- ↑ P. N. Tandon (2017). "Neuorosciences, an Overview" (PDF). Indian Academy of Neurosciences.
- ↑ "On ResearchGate". On ResearchGate. 2017.
- ↑ B Banerjee; T.C. Chaudhuri (9 January 2005). Therapeutic Effects of Tea. Science Publishers. pp. 44–. ISBN 978-1-57808-398-5.
- ↑ Ivan A. Ross (28 October 2007). Medicinal Plants of the World, Volume 3: Chemical Constituents, Traditional and Modern Medicinal Uses. Springer Science & Business Media. pp. 20–. ISBN 978-1-59259-887-8.
- ↑ Christian Rätsch (25 April 2005). The Encyclopedia of Psychoactive Plants: Ethnopharmacology and Its Applications. Inner Traditions / Bear & Co. pp. 510–. ISBN 978-1-59477-662-5.
- ↑ "Indian Academy of Neurosciences fellows". Indian Academy of Neurosciences. 2017.
- ↑ "View Bhatnagar Awardees". Shanti Swarup Bhatnagar Prize. 2016. Retrieved November 12, 2016.
External links
- "On PubMed". List of articles. US National Library of Medicine. 2016.
Further reading
- Ganguly DK, Malhotra CL (1967). "Some behavioural effects of an active fraction from Herpestis monniera, Linn. (Brahmi)" (PDF). Indian J Med Res. pp. 473–82. PMID 6065425.